Telix Pharmaceuticals Limited (TLX) Earnings History
Annual and quarterly earnings data from 2017 to 2024
Loading earnings history...
TLX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TLX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 65.1% | 10.5% | 6.4% |
| 2023 | 62.6% | 10.3% | 1.0% |
| 2022 | 18.3% | -57.4% | -65.0% |
| 2021 | -391.9% | -1069.6% | -1059.9% |
| 2020 | -323.7% | -944.8% | -861.1% |
Download Data
Export TLX earnings history in CSV or JSON format
Free sign-in required to download data
Telix Pharmaceuticals Limited (TLX) Earnings Overview
As of May 8, 2026, Telix Pharmaceuticals Limited (TLX) reported trailing twelve-month net income of $66M, reflecting +769.6% year-over-year growth. The company earned $0.20 per diluted share over the past four quarters, with a net profit margin of 6.4%.
Looking at the long-term picture, TLX's historical earnings data spans multiple years. The company achieved its highest annual net income of $50M in fiscal 2024, representing a new all-time high.
Telix Pharmaceuticals Limited maintains positive profitability with a gross margin of 65.1%, operating margin of 10.5%, and net margin of 6.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including EXEL ($833M net income, 33.7% margin), RNW ($11.97B net income, 3.9% margin), AGEN ($115,000 net income, 0.1% margin), TLX has room to improve margins relative to the peer group. Compare TLX vs EXEL →
TLX Earnings vs Peers
Earnings metrics vs comparable public companies
TLX Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $50M | +858.0% | $82M | $0.14 | 6.4% | 10.5% |
| 2023 | $5M | +105.0% | $52M | $0.02 | 1.0% | 10.3% |
| 2022 | -$104M | -29.3% | -$92M | $-0.34 | -65.0% | -57.4% |
| 2021 | -$81M | -79.4% | -$81M | $-0.29 | -1059.9% | -1069.6% |
| 2020 | -$45M | -61.1% | -$49M | $-0.17 | -861.1% | -944.8% |
| 2019 | -$28M | -101.5% | -$40M | $-0.12 | -799.6% | -1155.1% |
| 2018 | -$14M | -116.9% | -$16M | $-0.07 | -7087.1% | -8037.7% |
| 2017 | -$6M | - | -$6M | $-0.05 | - | - |
See TLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TLX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTLX — Frequently Asked Questions
Quick answers to the most common questions about buying TLX stock.
Is TLX growing earnings?
TLX EPS is $0.20, with earnings growth accelerating to +769.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $66M.
What are TLX's profit margins?
Telix Pharmaceuticals Limited net margin is +6.4%, with operating margin at +10.5%. Margins sit within typical range for the sector.
How consistent are TLX's earnings?
TLX earnings data spans 2017-2024. The accelerating earnings trend is +769.6% YoY. Historical data enables comparison across business cycles.